Ingersoll Rand(NYSE) IR

Ingersoll Rand makes machines that move air and liquids for factories and hospitals. These tools help businesses create energy, package food, and treat wastewater. The company serves people in many fields, from doctors to industrial manufacturers.

What They Build and Sell

• Industrial Technologies and Services: Air compressors, vacuum pumps, and power tools for factories and assembly lines; accounted for 36.5% of total revenue from aftermarket services and parts in 2025.
• Precision and Science Technologies: Specialized pumps and fluid systems for medical labs, water treatment, and chemical processing.
• Compression Products: Technology to increase air or gas pressure used to power heavy machinery and material handling systems.
• Vacuum and Blower Products: Systems that remove air to create a vacuum for food packaging or blow air to aerate wastewater.
• Life Science Tools: Specialized systems for handling delicate powders and liquids in the production of medicines.

Growth Through Strategic Deals

• Acquired SSI Aeration, Inc. in February 2025 for $97.8 million to expand wastewater treatment offerings.
• Purchased Termomeccanica Industrial Compressors S.p.A. and its subsidiary Adicomp S.p.A. in July 2025 for $193.2 million.
• Repurchased $1.02 billion of common stock during 2025 to return value to shareholders.
• Paid $31.8 million in cash dividends to stockholders during the fiscal year 2025.

What Sets Them Apart

The company maintains a vast global footprint with over 60 manufacturing facilities and 50 service centers across six continents. A significant portion of its business comes from selling replacement parts and services for its large existing base of installed machines.

The Financial Scorecard

• Revenue reached $2.1 billion in Q4 2025, up 10.1% from the previous year.
• Operating income grew to $663.6 million in Q4 2025, a 75.2% increase year-over-year.
• Net income hit $266.1 million in Q4 2025, up 15.8% compared to Q4 2024.
• Free cash flow was $461.5 million in Q4 2025, down 6% from $490.9 million in the prior year.
• International sales accounted for 58% of total revenue for the year ended December 31, 2025.

The Path Forward

Ingersoll Rand has shifted from a general machinery maker to a specialist in high-tech flow and life science solutions. Its focus on recurring service revenue and strategic acquisitions supports its position in the industrial and medical markets.